Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Atherosclerosis and SCAP[original query] |
---|
Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin. Journal of molecular medicine (Berlin, Germany) 2002 Nov 80 (11): 737-44. Salek Lorraine, Lutucuta Silvia, Ballantyne Christie M, Gotto Jr Antonio M, Marian A |
Expression of sterol regulatory element-binding transcription factor (SREBF) 2 and SREBF cleavage-activating protein (SCAP) in human atheroma and the association of their allelic variants with sudden cardiac death. Thrombosis journal 2008 6 (1): 17. Fan Yue-Mei, Karhunen Pekka J, Levula Mari, Ilveskoski Erkki, Mikkelsson Jussi, Kajander Olli A, Järvinen Otso, Oksala Niku, Thusberg Janita, Vihinen Mauno, Salenius Juha-Pekka, Kytömäki Leena, Soini Juhani T, Laaksonen Reijo, Lehtimäki Ter |
Dietary macronutrients, genetic variation, and progression of coronary atherosclerosis among women. American heart journal 2014 Apr 167 (4): 627-635.e1. Kalantarian Shadi, Rimm Eric B, Herrington David M, Mozaffarian Dariu |
NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease. Scientific reports 2020 3 10 (1): 4528. Bindesbøll Christian, Aas Aleksander, Ogmundsdottir Margret Helga, Pankiv Serhiy, Reine Trine, Zoncu Roberto, Simonsen An |
- Page last reviewed:Feb 1, 2024
- Content source: